| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212380 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 28 Pages |
Abstract
Elderly patients with good health and performance status may live long enough to experience disease progression from OCSCC. ECOG and HN-CCI scores may be useful to evaluate the candidacy of elderly patients for adjuvant therapy. However, the benefit of adjuvant therapy in this population remains elusive and should be investigated prospectively.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jie Jane BA, Jennifer L. MD, Jeremy P. MD, MPhil, Timothy T. BS, Kurt MD, Christina S. MD, Michael J. MD, Vasu MD, David MD, Quynh-Thu MD, Wendy Y. MD,